Search results

1 – 10 of 21
Open Access
Article
Publication date: 11 February 2013

Robert G. Bota

Abstract

Details

Mental Illness, vol. 5 no. 1
Type: Research Article
ISSN: 2036-7465

Open Access
Article
Publication date: 11 February 2013

Robert G. Bota

Abstract

Details

Mental Illness, vol. 5 no. 1
Type: Research Article
ISSN: 2036-7465

Open Access
Article
Publication date: 19 October 2017

Nare Torosyan and Robert G. Bota

Abstract

Details

Mental Illness, vol. 9 no. 2
Type: Research Article
ISSN: 2036-7465

Keywords

Abstract

Details

Mental Illness, vol. 7 no. 2
Type: Research Article
ISSN: 2036-7465

Keywords

Open Access

Abstract

Details

Mental Illness, vol. 6 no. 2
Type: Research Article
ISSN: 2036-7465

Open Access
Article
Publication date: 24 February 2015

Victor Cisneros, Iliya Goldberg, Amanda Schafenacker and Robert G. Bota

Abstract

Details

Mental Illness, vol. 7 no. 1
Type: Research Article
ISSN: 2036-7465

Open Access
Article
Publication date: 23 November 2016

Cristina Vladu, Andrei Novac, Adrian Preda and Robert G. Bota

Abstract

Details

Mental Illness, vol. 8 no. 2
Type: Research Article
ISSN: 2036-7465

Keywords

Open Access

Abstract

Details

Mental Illness, vol. 6 no. 2
Type: Research Article
ISSN: 2036-7465

Open Access
Article
Publication date: 6 November 2018

Bharat R. Sampathi, Anna Sofine, John Alvarez and Robert Bota

Capgras Syndrome is a subcategory of delusional disorder. People affected by this syndrome believe that a close associate such as a friend or family member has been replaced by an…

Abstract

Capgras Syndrome is a subcategory of delusional disorder. People affected by this syndrome believe that a close associate such as a friend or family member has been replaced by an identical imposter. This case report describes a 23-year-old woman with no prior psychiatric history, whom developed Capgras syndrome, via folie a deux, in the setting of poly-substance use. In this patient, a combination of Aripiprazole 10 mg daily and Escitalopram 10 mg daily were effective in resolving symptoms. Clonazepam was utilized for anxiety and Omega-3 fatty acids 1 g for anti-oxidative effects. Further studies are needed to investigate the effects of a variety of causes and treatments for Capgras Syndrome.

Details

Mental Illness, vol. 10 no. 2
Type: Research Article
ISSN: 2036-7465

Keywords

Open Access
Article
Publication date: 22 March 2019

Jody Jacobson Wedret, Thanh G. Tu, Doru Paul, Camille Rousseau, Augustin Bonta and Robert G. Bota

Depression and insomnia are very significant pathologies in cancer patients as they contribute to the patient's overall cure and quality of life. Moreover, untreated depression…

Abstract

Depression and insomnia are very significant pathologies in cancer patients as they contribute to the patient's overall cure and quality of life. Moreover, untreated depression and ongoing insomnia are associated with decreased immune responses and lower survival rates. With all disease states and especially with cancer, close attention to drug-drug interactions and the potential impact on the efficacy of therapy is paramount. One area of particular interest due to the lack of well-done clinical trials is drug-drug interaction(s) between antidepressants and cancer treatment. Pharmacokinetics of a certain drug allows for prediction of certain drug interactions based on chemical properties of the agents involved. If the agents depend on their metabolites for activity, active drug level will be decreased through this enzyme inhibition. In this paper, we looked at the cytochrome-P450 drug interactions between antidepressants and sleep aids with Selective Estrogen Receptor Modulators (SERM). Newer SERM metabolisms are less influenced by interactions with medications used to treat depression. However, tamoxifen metabolism could be severely altered by several antidepressants. This has direct consequences as patients on tamoxifen and antidepressant can have double the risk of relapse to cancer in two years. We discussed those interactions and made recommendations for clinical use.

Details

Mental Illness, vol. 11 no. 1
Type: Research Article
ISSN: 2036-7465

Keywords

1 – 10 of 21